Citation Impact
Citing Papers
Antibody–Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
2019
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)
2014 Standout
Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
2018
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
Intratympanic Methylprednisolone in Refractory Sudden Hearing Loss
2009
Bisphenol A and human health: A review of the literature
2013 Standout
Impact of Lithium on Efficacy of Radioactive Iodine Therapy for Graves’ Disease: A Cohort Study on Cure Rate, Time to Cure, and Frequency of Increased Serum Thyroxine After Antithyroid Drug Withdrawal
2009
The Thyroid Nodule
2004 Standout
EANM procedure guidelines for therapy of benign thyroid disease
2010
New perspectives for synergy research with the “omic”-technologies
2009
Radioiodine treatment for benign thyroid diseases
2007
Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals
2013
The Use of Computed Tomography in Pediatrics and the Associated Radiation Exposure and Estimated Cancer Risk
2013 Standout
Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study
2012 Standout
Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity
2008
Antithyroid Drugs in the Management of Patients with Graves’ Disease: An Evidence-Based Approach to Therapeutic Controversies
2003
Inner ear drug delivery for auditory applications
2008
8thAnnual European Antibody Congress 2012
2013
Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies
2006
Failure of Radioactive Iodine in the Treatment of Hyperthyroidism
2014
Intratympanic Dexamethasone for Sudden Sensorineural Hearing Loss After Failure of Systemic Therapy
2007
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
The effects of recombinant human thyrotropin, in normal subjects and patients with goitre
2004
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Early Transtympanic Steroid Injection in Patients with ‘Poor Prognosis’ Idiopathic Sensorineural Sudden Hearing Loss
2010
rhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer
2013
Lithium and thyroid
2009
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
The Use of Three-Dimensional Ultrasound for Thyroid Volumetry
2001
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
2008
Intratympanic corticosteroid for sudden hearing loss: does it really work?
2015
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Biostimulants in Plant Science: A Global Perspective
2017 Standout
Management of Simple Nodular Goiter: Current Status and Future Perspectives
2003
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
2014
Cumulative Effective Doses From Radiologic Procedures for Pediatric Oncology Patients
2010
The oncolytic virusdl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma
2015
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer
2010
Intratympanic Steroids for Inner Ear Disorders: A Review
2009
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
2012
Administration of substances to laboratory animals: routes of administration and factors to consider.
2011 Standout
Clinical Practice Guideline
2012
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Clinical Practice Guideline: Sudden Hearing Loss (Update)
2019 Standout
Guidelines for the management of thyroid cancer
2014 Standout
TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis
2012
Works of Claudio Traino being referenced
Comparison of Different Thyroid Committed Doses in Radioiodine Therapy for Graves' Hyperthyroidism
2005
Influence of total-body mass on the scaling ofS-factors for patient-specific, blood-based red-marrow dosimetry
2007
Possibility of limiting the un-justified irradiation in 131I therapy of Graves' disease: A thyroid mass-reduction based method for the optimum activity calculation
2009
Transtympanic Steroids as a Salvage Therapy in Sudden Hearing Loss: Preliminary Results
2006
Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism
1999
Cumulative patient effective dose in cardiology
2008
A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with131I
2005
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal
2007
Treatment with Drugs Able to Reduce Iodine Efflux Significantly Increases the Intracellular Retention Time in Thyroid Cancer Cells Stably Transfected with Sodium Iodide Symporter Complementary Deoxyribonucleic Acid
2006
Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
2012
Treatment with Lithium Prevents Serum Thyroid Hormone Increase after Thionamide Withdrawal and Radioiodine Therapy in Patients with Graves’ Disease
2002
Accuracy of two simple methods for estimation of thyroidal kinetics for dosimetry‐based treatment of Graves’ disease
2009
A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves$apos$ disease
2002
The Effect of Ginkgo biloba Extract on Genotoxic Damage in Patients with Differentiated Thyroid Carcinoma Receiving Thyroid Remnant Ablation with Iodine-131
2011
Anticlastogenic Effect of Ginkgo Biloba Extract in Graves’ Disease Patients Receiving Radioiodine Therapy
2007
Chromosome Translocation Frequency after Radioiodine Thyroid Remnant Ablation: A Comparison between Recombinant Human Thyrotropin Stimulation and Prolonged Levothyroxine Withdrawal
2009